High-risk B-cell acute lymphoblastic leukaemia presenting with hypereosinophilia and acquiring a novel PAX5 fusion on relapse

Br J Haematol. 2020 Oct;191(2):301-304. doi: 10.1111/bjh.17002. Epub 2020 Jul 30.
No abstract available

Keywords: B-ALL; Leukaemia; PAX5; Ph-like; hypereosinophilia.

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Humans
  • Hypereosinophilic Syndrome* / genetics
  • Hypereosinophilic Syndrome* / metabolism
  • Hypereosinophilic Syndrome* / pathology
  • Immunoglobulin Heavy Chains* / genetics
  • Immunoglobulin Heavy Chains* / metabolism
  • Interleukin-3* / genetics
  • Interleukin-3* / metabolism
  • Male
  • Oncogene Proteins, Fusion* / genetics
  • Oncogene Proteins, Fusion* / metabolism
  • PAX5 Transcription Factor* / genetics
  • PAX5 Transcription Factor* / metabolism
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma* / genetics
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma* / metabolism
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma* / pathology

Substances

  • IL3 protein, human
  • Immunoglobulin Heavy Chains
  • Interleukin-3
  • Oncogene Proteins, Fusion
  • PAX5 Transcription Factor
  • PAX5 protein, human